Comprehensive Clinical Development is clinical research company focusing on clinical pharmacology, central nervous system (CNS) and oncology trials.
Comprehensive continues to dominate the therapeutic development process by standing as a strategic partner – poised with deep expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs.
Comprehensive is dedicated to open and effective communication at all organizational levels, and to supporting sponsor confidence through simplified contracting, timely enrollment, proactive trial execution and quality data delivery. Comprehensive delivers accelerated product development, integrated clinical trial management and high quality research services for all phases.
- Clinical Pharmacology Units - a leader in providing early phase investigative services since 1994 with outstanding expertise in rapid study startup, complex study methodologies and medical technologies, and special populations.
- CNS Investigator Sites - a group of five wholly-owned investigative sites managed by full time Principal Investigators and Clinical Site Directors with extensive clinical trials research experience, particularly in the area of central nervous system drugs. These Investigators collaboratively have conducted the most central nervous system (CNS) research in the industry.